A new study published in the May 2026 issue of Anesthesiology exposes challenges in reversing opioid overdoses with naloxone when potent synthetic drugs like fentanyl and sufentanil are involved. Researchers found that a single dose may not fully reverse respiratory depression, and that patients may appear awake before breathing has fully recovered—urging institutions to update guidelines and reinforce the importance of fast emergency intervention.

Full study: New Study Shows Limitations of Naloxone in Reversing Overdoses from Powerful Synthetic Opioids